Are OKT3 binding sites on T cells modulated or merely converted (blindfolded) by OKT3 during therapy?

Journal article

Peer reviewed

M Carreno, J Miller, V Esquenazi, M Milgrom, D Roth and L Fuller

Transplantation proceedings, Vol.21(1 Pt 1), pp.987-988

1989-02

PMID: 2565060

Abstract

Antigens, Differentiation, T-Lymphocyte - immunology

CD3 Complex

Humans

Antibodies, Monoclonal - therapeutic use

Kidney Transplantation

Receptors, Immunologic - analysis

Antigens, Differentiation, T-Lymphocyte - analysis

CD2 Antigens

Lymphocytes - immunology

Antibodies, Monoclonal - analysis

Receptors, Antigen, T-Cell - analysis

Radioimmunoassay

Graft Rejection

Receptors, Antigen, T-Cell - immunology

Receptors, Immunologic - immunology

Antigens, Surface - immunology

7 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.286 Immunology & Hematology; 1.286.845 Complement
Web Of Science research areas: Immunology; Surgery; Transplantation
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Are OKT3 binding sites on T cells modulated or merely converted (blindfolded) by OKT3 during therapy?
Creators: M Carreno - Department of Surgery, University of Miami School of Medicine, Florida 33101
J Miller
V Esquenazi
M Milgrom
D Roth
L Fuller
Publication Details: Transplantation proceedings, Vol.21(1 Pt 1), pp.987-988
Grant note: 25243-09 / PHS HHS
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Nephrology & Hypertension Div
Language: English
Resource Type: Journal article
PMID: 2565060
Record Identifier: 991031600426402976